Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Leukemia, Myeloid, Acute 8Myelodysplastic Syndromes 7Mastocytosis, Systemic 4Leukemia, Mast-Cell 3Leukemia 2Aggression 2Mastocytosis 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1GATA2 Deficiency 1Congenital Abnormalities 1Blast Crisis 1

Interventions

masitinib 4Imatinib Mesylate 3midostaurin 1fludarabine phosphate 1fludarabine 1avapritinib 1Whole-Body Irradiation 1Watchful Waiting 1Transplantation 1Tacrolimus 1Stem Cell Transplantation 1Sodium Chloride 1Single-Cell Gene Expression Analysis 1Radiotherapy 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Mass Screening 1Injections 1Hydroxychloroquine 1Dasatinib 1Cyclophosphamide 1Cromolyn Sodium 1Cladribine 1Busulfan 1BNT162 Vaccine 1AK002 12019-nCoV Vaccine mRNA-1273 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mastocytosis × midostaurin × Myeloid × Clear all
NCT01920204 2015-01-19

Midostaurin in Indolent Systemic Mastocytosis

University Medical Center Groningen

Phase 2 Unknown
20 enrolled
Myeloid

Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡